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In the era of coronavirus disease 2019 (COVID-19), limited utilization of medical facilities 
is one of the big issues in clinical practice. However, patients with suspected COVID-19 
pneumonia should be evaluated systemically not just for lung, but also for cardiac 
involvement.1)2) The usual approach to patients with acute respiratory symptoms is chest 
X-ray and computed tomography (CT) scans, in accordance with blood biomarker studies. 
In addition, to differentiate cardiac origin of dyspnea, echocardiography is widely used in 
combination with electrocardiography and blood biomarkers. However, in the COVID-19 
pandemic, sanitization is crucial after chest X-ray, CT, or echocardiography examination in 
suspected COVID-19 infection. This requires much more human and economic resources 
and raises the needs for rapid, portable but reliable bedside equipment for cardiopulmonary 
evaluation. Point-of-care ultrasound (PCOUS) including echocardiography and lung 
ultrasound (LUS) fits this purpose for use in the emergency room, intensive care unit (ICU), 
and outside the hospital, especially in patients on a mechanical ventilator. LUS is superior 
to supine portable chest X-ray for rapid evaluation of pneumothorax, alveolar interstitial 
pattern, consolidation, and pleural effusion. In addition, it has the advantages of immediate 
bedside availability, repeatability, cost saving, and reduction in radiation exposure.
The paper by Bitar et al.3) in this issue noted the usefulness of POCUS (Echo and LUS) to 
differentiate severe acute respiratory syndrome coronavirus 2 infection in patients with 
acute respiratory distress symptoms in the ICU. In the study, bedside echocardiography was 
useful to differentiate cardiac origin of dyspnea by lower E/e′ and absence of inferior vena 
cava plethora. In addition, right ventricular thrombus, pulmonary embolism, and right 
ventricular dysfunction, which are sometimes combined in COVID-19 pneumonia, can be 
detected by POCUS with echocardiography. The most important finding in this study is that 
typical patterns of LUS were significantly correlated to confirmative diagnosis of COVID-19 
pneumonia. The LUS revealed four signs suggestive of COVID-19 pneumonia in 77 patients 
(98.6%) (sensitivity, 96.9%; 85% confidence interval, 99.5%) compared with reverse 
transcription-polymerase chain reaction results. The aeration score was significantly higher 
for COVID-19 pneumonia (p = 0.018), as was the total number of subpleural consolidations 
in the 12 zones of the chest (p < 0.0001). This finding is consistent with previous studies 
of COVID-19.3)4) According to recommendation for LUS from the European Association of 
Echocardiography and American Society of Echocardiography, there are specific patterns for 
COVID-19 pneumonia, as shown in the Table 1.5) However, in clinical situations, as disease 
symptoms can overlap, patient care should be based on “Point-of-Care Ultrasound” as well as 
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► See the article “Point-of-Care Ultrasound for COVID-19 Pneumonia Patients in the ICU” in volume 29 
on page 60.
“Point-of-Care Integration.” Based on the likelihood of another viral pandemic or epidemic 
at some point in the future, physicians involved in patient care of infectious disease, cardiac 
diseases, or respiratory diseases in a critical care unit or emergency department should 
become experts in POCUS with LUS and echocardiography.
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POCUS for COVID-19 Pneumonia
Table 1. Typical signs of COVID-19 and aeration score on lung ultrasound
The 4 signs of COVID-19 pneumonia on lung ultrasound5)
1.  Bilateral B-lines in both separate and coalescent forms, sometimes patchy, frequently giving the appearance of 
a shining white lung. The B lines maintain their brightness to the end of the screen.
2. Bilateral diffuse irregularities of the pleural line.
3. Absence of significant pleural effusion.
4. Presence of multiple subpleural consolidations of various sizes.
COVID-19: coronavirus disease 2019.
